Drug Trial Radar · NCT05382338
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Last checked: Nov 19, 2026Latest source record: Aug 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
225
Planned (sponsor's estimate)
Start
Feb 20, 2023
Primary completion
Dec 31, 2029
Study completion Dec 31, 2029
Sponsor
- Lead sponsor
- Children's Oncology GroupResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- First posted
- May 19, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 4 years, up to 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase III trial tests two hypotheses in patients with low-risk and average-risk medulloblastoma. Medulloblastoma is a type of cancer that occurs in the back of the brain. The term, risk, refers to the chance of the cancer coming back after treatment. Subjects with low-risk medulloblastoma typically have a lower chance of the cancer coming back than subjects with average-risk medulloblastoma. Although treatment for newly diagnosed average-risk and low-risk medulloblastoma is generally effective at treating the cancer, there are still concerns about the side effects of such treatment. Side effects or unintended health conditions that arise due to treatment include learning difficulties, hearing loss or other issues in performing daily activities. Standard therapy for newly diagnosed average-risk or low-risk medulloblastoma includes surgery, radiation therapy, and chemotherapy (including cisplatin). Cisplatin may cause hearing loss as a side effect. In the average-risk medulloblastoma patients, this trial tests whether the addition of sodium thiosulfate (STS) to standard of care chemotherapy and radiation therapy reduces hearing loss. Previous studies with STS have shown that it may help reduce or prevent hearing loss caused by cisplatin. In the low-risk medulloblastoma patients, the study tests whether a less intense therapy (reduced radiation) can provide the same benefits as the more intense therapy. The less intense therapy may cause fewer side effects. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. The overall goals of this study are to see if giving STS along with standard treatment (radiation therapy and chemotherapy) will reduce hearing loss in medulloblastoma patients and to compare the overall outcome of patients with medulloblastoma treated with STS to patients treated without STS on a previous study in order to make sure that survival and recurrence of tumor is not worsened.
Conditions
- Childhood Medulloblastoma
Interventions
Audiometric TestProcedure
Ancillary studies
Auditory Brainstem ResponseProcedure
Ancillary studies
Biospecimen CollectionProcedure
Undergo CSF and blood sample collection
CisplatinDrug
Given IV
CyclophosphamideDrug
Given IV
LomustineDrug
Given PO
Magnetic Resonance ImagingProcedure
Undergo MRI
Quality-of-Life AssessmentOther
Ancillary studies
Radiation TherapyRadiation
Undergo radiation therapy
Sodium ThiosulfateDrug
Given IV
Survey AdministrationOther
Ancillary studies
VincristineDrug
Given IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of patients with >= grade 2 hearing lossTime frame: At 4 weeks after the last dose of cisplatin
- Event-free survival (EFS)Time frame: From initiation of the protocol treatment to the occurrence of disease progression, disease recurrence, death from any cause, or occurrence of a second malignant neoplasm, assessed up to 10 years
Locations
111 sites in 2 countries. Site status is shown where the registry gives one.
Children's Hospital of Alabama
Birmingham, Alabama · Active not recruiting
USA Health Strada Patient Care Center
Mobile, Alabama · Recruiting
Phoenix Childrens Hospital
Phoenix, Arizona · Recruiting
Arkansas Children's Hospital
Little Rock, Arkansas · Recruiting
Loma Linda University Medical Center
Loma Linda, California · Recruiting
Miller Children's and Women's Hospital Long Beach
Long Beach, California · Recruiting
Children's Hospital Los Angeles
Los Angeles, California · Recruiting
Valley Children's Hospital
Madera, California · Recruiting
Kaiser Permanente-Oakland
Oakland, California · Recruiting
Children's Hospital of Orange County
Orange, California · Recruiting
University of California Davis Comprehensive Cancer Center
Sacramento, California · Recruiting
Rady Children's Hospital - San Diego
San Diego, California · Recruiting
UCSF Medical Center-Mission Bay
San Francisco, California · Recruiting
Children's Hospital Colorado
Aurora, Colorado · Recruiting
Connecticut Children's Medical Center
Hartford, Connecticut · Recruiting
Yale University
New Haven, Connecticut · Recruiting
Alfred I duPont Hospital for Children
Wilmington, Delaware · Recruiting
Children's National Medical Center
Washington D.C., District of Columbia · Recruiting
Golisano Children's Hospital of Southwest Florida
Fort Myers, Florida · Recruiting
Memorial Regional Hospital/Joe DiMaggio Children's Hospital
Hollywood, Florida · Recruiting
Nemours Children's Clinic-Jacksonville
Jacksonville, Florida · Recruiting
University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida · Recruiting
Nicklaus Children's Hospital
Miami, Florida · Recruiting
Arnold Palmer Hospital for Children
Orlando, Florida · Recruiting
Nemours Children's Hospital
Orlando, Florida · Recruiting
Nemours Children's Clinic - Pensacola
Pensacola, Florida · Recruiting
Johns Hopkins All Children's Hospital
St. Petersburg, Florida · Recruiting
Saint Joseph's Hospital/Children's Hospital-Tampa
Tampa, Florida · Recruiting
Children's Healthcare of Atlanta - Arthur M Blank Hospital
Atlanta, Georgia · Recruiting
Kapiolani Medical Center for Women and Children
Honolulu, Hawaii · Recruiting
University of Illinois
Chicago, Illinois · Recruiting
OSF Children's Hospital of Illinois
Peoria, Illinois · Recruiting
Southern Illinois University School of Medicine
Springfield, Illinois · Recruiting
Riley Hospital for Children
Indianapolis, Indiana · Recruiting
Blank Children's Hospital
Des Moines, Iowa · Recruiting
University of Iowa/Holden Comprehensive Cancer Center
Iowa City, Iowa · Recruiting
Norton Children's Hospital
Louisville, Kentucky · Recruiting
Children's Hospital New Orleans
New Orleans, Louisiana · Recruiting
Sinai Hospital of Baltimore
Baltimore, Maryland · Recruiting
Johns Hopkins University/Sidney Kimmel Cancer Center
Baltimore, Maryland · Recruiting
Showing 40 of 111 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.